Jazz Pharmaceuticals plc 4
4 · Jazz Pharmaceuticals plc · Filed Mar 6, 2014
Insider Transaction Report
Form 4
Keegan Fintan
EVP, Technical Operations
Transactions
- Sale
Ordinary Shares
[F1]2014-03-04$161.00/sh−3,006$483,966→ 40,906 total - Sale
Ordinary Shares
[F1]2014-03-06$157.89/sh−1,634$257,992→ 39,272 total
Footnotes (1)
- [F1]Shares sold to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
Signature
/s/ Larissa Schwartz as attorney in fact for Fintan Keegan|2014-03-06